Table 1 Details of HIV-1 patients and... | American Society of Hematology

Table 1

Details of HIV-1 patients and healthy controls

	Stockholm cohort			San Francisco cohort
	HIV−	HIV+	P	HIV−	HIV+	P
n	34	33		9	11
Age, y‡	37.5 (30-51.3)	39 (34.5-47)	.94*	46 (45-50.2)	47 (28-52)	.56*
Sex, n (%)	16 M (47.1%)	21 M (63.6%)	.51*	9 M (100%)	9 M (81.8%)	.48*
CD4 counts, cells/μL	ND	446 ± 54		ND	494 ± 58	.21†
Viral loads, copies/mL	NA	78 739 ± 31 580		NA	137 000 ± 100 005	.46†
Time since HIV diagnosis, mo	NA	85 ± 11		NA	110 ± 30	.34†

	Stockholm cohort			San Francisco cohort
	HIV−	HIV+	P	HIV−	HIV+	P
n	34	33		9	11
Age, y‡	37.5 (30-51.3)	39 (34.5-47)	.94*	46 (45-50.2)	47 (28-52)	.56*
Sex, n (%)	16 M (47.1%)	21 M (63.6%)	.51*	9 M (100%)	9 M (81.8%)	.48*
CD4 counts, cells/μL	ND	446 ± 54		ND	494 ± 58	.21†
Viral loads, copies/mL	NA	78 739 ± 31 580		NA	137 000 ± 100 005	.46†
Time since HIV diagnosis, mo	NA	85 ± 11		NA	110 ± 30	.34†

ND indicates not done; NA, not applicable; and M, male.

Comparisons were done on uninfected versus HIV-infected patients.

Comparisons were done on HIV-infected patients recruited in Stockholm versus San Francisco.

Median (IQR); mean ± SD shown for all parameters unless otherwise specified.